Valsartan / Cilnidipine Combination Tablets 80mg/10mg (Atedio® / アテディオ配合錠)

JPY ¥3,800

Japanese Selective AT1 Receptor Blocker / Long-acting Calcium Channel Blocker Combination (Valsartan 80mg / Cilnidipine 10mg). Oral antihypertensive combination tablet administered once daily after breakfast. 100 tablets (PTP, 10 tablets x 10). Mfd. by EA Pharma Co., Ltd., Japan.

Bulk deal
Quantity Discount Discounted price
5 - 9 8% JPY ¥3,496
10 - 19 12% JPY ¥3,344
20 + 18% JPY ¥3,116
SKU: ATD-8010-TAB Category:

Description

Product Overview / 商品概要

Atedio Combination Tablets (Valsartan 80mg / Cilnidipine 10mg) (アテディオ配合錠)
Generic: Valsartan / Cilnidipine Combination Tablets / バルサルタン・シルニジピン配合錠
Therapeutic Category: Selective AT1 Receptor Blocker / Long-acting Calcium Channel Blocker Combination / 選択的AT1受容体ブロッカー・持続性Ca拮抗薬合剤
Manufactured by: EA Pharma Co., Ltd. / EAファーマ株式会社

Composition & Specification / 組成・規格

Active Ingredient: Valsartan 80mg and Cilnidipine 10mg per tablet / 1錠中バルサルタン80mg、シルニジピン10mg
Additives: Magnesium aluminometasilicate, Microcrystalline cellulose, Lactose hydrate, Macrogol 400, Croscarmellose sodium, Hydroxypropylcellulose, Hypromellose phthalate, Hydrous silicon dioxide, Magnesium stearate, Hypromellose, Macrogol 6000, Titanium oxide, Yellow ferric oxide, Carnauba wax / メタケイ酸アルミン酸マグネシウム、結晶セルロース、乳糖水和物、マクロゴール400、クロスカルメロースナトリウム、ヒドロキシプロピルセルロース、ヒプロメロースフタル酸エステル、含水二酸化ケイ素、ステアリン酸マグネシウム、ヒプロメロース、マクロゴール6000、酸化チタン、黄色三二酸化鉄、カルナウバロウ
Appearance: Light yellow, oval-shaped film-coated tablet. Major axis approx. 16.3mm, minor axis approx. 7.2mm, thickness approx. 5.0mm, weight approx. 0.52g. Imprint: ATEDIO
外観: 淡黄色の楕円形のフィルムコーティング錠。長径 約16.3mm、短径 約7.2mm、厚さ 約5.0mm、重量 約0.52g。表面:ATEDIO

Indications / 効能効果

EN: Hypertension
JA: 高血圧症

Dosage and Administration / 用法用量

EN: Orally administer 1 tablet (Valsartan 80mg and Cilnidipine 10mg) once daily after breakfast to adults. This product should not be used as a first-line antihypertensive therapy.
JA: 成人には1日1回1錠(バルサルタンとして80mg及びシルニジピンとして10mg)を朝食後に経口投与する。本剤は高血圧治療の第一選択薬として用いない。

Contraindications / 禁忌

EN: Patients with a history of hypersensitivity to any component of this product; pregnant women or women who may be pregnant; diabetic patients receiving aliskiren fumarate (except those with markedly poor blood pressure control despite other antihypertensive treatments)
JA: 本剤の成分に対し過敏症の既往歴のある患者、妊婦又は妊娠している可能性のある女性、アリスキレンフマル酸塩を投与中の糖尿病患者(ただし、他の降圧治療を行ってもなお血圧のコントロールが著しく不良の患者を除く)

Regulatory Information / 規制情報

Approval No.: 22600AMX00534
Sales Started: May 2014 / 2014年5月
Classification Code: 872149
Storage: Store at room temperature / 室温保存
Shelf Life: 3 years / 3年

Packaging / 包装

Main Package (for sale): 100 tablets (PTP, 10 tablets x 10) / 100錠(PTP、10錠×10)
Other Available Packages (by special order): 100 tablets (PTP, 10 tablets x 10), 500 tablets (PTP, 10 tablets x 50), 500 tablets (polyethylene bottle, bulk, with desiccant)

Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.

Additional information

重さ 0.15 kg

Reviews

There are no reviews yet.

Be the first to review “Valsartan / Cilnidipine Combination Tablets 80mg/10mg (Atedio® / アテディオ配合錠)”

メールアドレスが公開されることはありません。 が付いている欄は必須項目です

Export from Japan — Valsartan

🏭 Supply & Origin

  • Country of Origin: Japan
  • Regulatory Standard: PMDA (Japan) / GMP Compliant
  • Pharmacopoeia: Japanese Pharmacopoeia (JP)
  • Supplier: Mate Co., Ltd. — Licensed Pharmaceutical Wholesaler (License No. B14309, Osaka)
  • Supply Capacity: Full-line sourcing through Japan's regulated distribution channels

🚚 Shipping & Trade Terms

  • Incoterms: FOB Kansai International Airport (KIX)
  • Shipping: Air freight via B/L or AWB
  • Payment: 100% T/T in advance
  • Lead Time: 2-4 weeks after payment confirmation
  • Available Regions: EU, LATAM, APAC, Middle East, Africa

Request a Quotation

For pricing, MOQ, and regulatory documentation, contact our export team:

Email: kurimoto@mate-osaka.co.jp
Tel: +81-72-665-5736

All exports are conducted through proper regulatory procedures including customs clearance, B/L or AWB documentation, and T/T advance payment. We do not engage in hand-carry, cash transactions, or sales to unlicensed parties.